-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-260-improved-cancer-outcomes-executive-summary_0.pdf
May 01, 2023 - Studies were predominately conducted in individuals with
gastrointestinal and head and neck cancers, … predominately
examined dietary supplements and nutrition support in gastrointestinal and head
and neck cancers … Studies were predominately conducted in populations with gastrointestinal and head and
neck cancers, … glutamine supplementation on the surgical
outcome after pancreaticoduodenectomy for
periampullary tumors … versus standard diet
following McKeown minimally invasive
esophagectomy in patients with esophageal
malignancy
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ghbfx9e3A6jQEqVW26y8Jv
March 09, 2021 - harms
Estimates were not provided for lifetime
risk of radiation-induced cancers or fatal
cancers from … across studies (range, 20%-80%) and by subgroups
defined by clinical characteristics (eg, operability of tumor … test performance and interval cancers. … Lung-RADS category 4X: does it improve prediction
of malignancy in subsolid nodules? … Extrapulmonary findings and malignancies in
participants screened with chest CT in the National
Lung
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
May 01, 2006 - (deficiency of red blood cells)
occurs in 13-78 percent of patients
undergoing treatment for solid tumors … Tumor type, treatment
regimen, and history of prior cancer
therapy influence the risk and severity of … For example, among patients with
solid tumors, the frequency of anemia
severe enough to require red blood … cell
transfusion is highest for those with lung,
gynecologic, and genitourinary tumors. … Whether
erythropoietic stimulants accelerate progression of
some cancers, as reported by one study (n
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-surveillance_research-protocol.pdf
May 19, 2011 - The cancer is often localized, and most tumors have low histological
grades and Gleason Scores. … half of them were expected to have
early stage, low-risk tumors.
1
Thus, management of early stage … Tumor Characteristics
i. Stage
ii. Tumor volume
iii. Gleason Score
iv. PSA
c. … In addition to prostate neoplasms/cancer, search terms will include “active
surveillance,” “watchful … Definition of Terms
TNM = Tumor stage, node involvement, and metastasis.
VII.
-
psnet.ahrq.gov/issue/errors-cancer-diagnosis-current-understanding-and-future-directions
November 18, 2009 - Errors in cancer diagnosis: current understanding and future directions. … Errors in cancer diagnosis: current understanding and future directions. … October 9, 2017
Safety and diagnostic accuracy of tumor biopsies in children with cancer … October 10, 2012
Rates of new or missed colorectal cancers after colonoscopy and their … August 10, 2011
Missed breast cancers at US-guided core needle biopsy: how to reduce
-
effectivehealthcare.ahrq.gov/products/liver-cancer/research
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-breast-cancer/breast-cancer-screening-january-2016
January 11, 2016 - defined by stage and tumor size). … Committee on Cancer TNM system based on tumor size, lymph node involvement, and presence of metastasis … one study. 82 A randomized trial of annual versus triennial screening indicated detection of more tumors … Third, studies used heterogeneous definitions for advanced breast cancer that did not consider tumor … size >20 mm: 22% vs. 24%
OR (for 2-y interval vs. 1-y interval
Late stage for invasive cancers
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
April 25, 2013 - The clinical trials in head-neck cancer patients
were designed to improve outcomes by increasing tumor … trials and a Cochrane head-neck review) involving
non-anemic patients with head-neck cancer, a malignancy … Page 23, line 27:
This discussion focuses on hematologic malignancies. … Information on anemia
prevalence in non-myeloid malignancies could be included here. … This has been revised to include non-myeloid
malignancies.
-
hcup-us.ahrq.gov/reports/statbriefs/sb253-Influenza-Hospitalizations-ED-Visits-2006-2016.pdf
January 01, 2016 - Cardiac cancers
NEO023 Bone cancer
NEO025 Skin cancers - melanoma
NEO028 Skin cancers - all other … cancers - peritoneum
NEO030 Breast cancer - all other types
NEO038 Female reproductive system cancers … Endocrine system cancers - pituitary gland
NEO069 Cancer of other sites
NEO070 Secondary malignancies … NEO066 Malignant neuroendocrine tumors
NEO071 Malignant neoplasm, unspecified
NEO057 Hodgkin lymphoma … Myelodysplastic syndrome (MDS)
NEO074 Conditions due to neoplasm or the treatment of neoplasm
FAC006
-
effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_disposition-comments.pdf
February 24, 2016 - and malignant disease (many
studies included only tumors confirmed to be
cancer). … tumors in the cohort. … applicability
to clinical decision making and the vast majority of patients presenting
with renal cortical neoplasms … The main
point is that larger tumors are associated with
malignancy, and that the OR of 1.3 gives a … who proceeds to surgery as patient or tumor
characteristics (i.e. male sex, larger tumors)
influence
-
www.uspreventiveservicestaskforce.org/uspstf/document/modeling-study/breast-cancer-screening
April 30, 2024 - cycles). 43-46 Based on published data, treatment benefit was therefore reduced by 28% for ER-negative tumors … Underlying incidence in the absence of screening and the proportion of tumors that were nonprogressive … Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and … for screening-detected and interval cancers. … 49, 50-64, 65-74, 75-89 y), screening round/interval (first, annual, biennial) for screen-detected cancers
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007v2_MaskedStats_Core_Weighted.PDF
April 09, 2010 - 14: Cancer of colon 34,920 0.03
15: Cancer of rectum and anus 11,581 0.01
16: Cancer of liver and … ; other and unspecified primary 3,239 0.00
42: Secondary malignancies 131,834 0.11
43: Malignant neoplasm … without specification of site 4,842 0.00
44: Neoplasms of unspecified nature or uncertain behavior … 33,714 0.03
45: Maintenance chemotherapy; radiotherapy 4,468 0.00
46: Benign neoplasm of uterus 33,499 … 0.03
47: Other and unspecified benign neoplasm 53,592 0.04
48: Thyroid disorders 37,454 0.03
49:
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2008_MaskedStats_Core_Weighted.PDF
January 01, 2008 - 14: Cancer of colon 35,317 0.03
15: Cancer of rectum and anus 11,280 0.01
16: Cancer of liver and … ; other and unspecified primary 3,229 0.00
42: Secondary malignancies 129,333 0.10
43: Malignant neoplasm … without specification of site 6,063 0.00
44: Neoplasms of unspecified nature or uncertain behavior … 34,086 0.03
45: Maintenance chemotherapy; radiotherapy 4,289 0.00
46: Benign neoplasm of uterus 35,571 … 0.03
47: Other and unspecified benign neoplasm 53,605 0.04
48: Thyroid disorders 38,390 0.03
49:
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007_MaskedStats_Core_Weighted.PDF
January 01, 2007 - 14: Cancer of colon 34,826 0.03
15: Cancer of rectum and anus 11,830 0.01
16: Cancer of liver and … ; other and unspecified primary 3,540 0.00
42: Secondary malignancies 129,279 0.11
43: Malignant neoplasm … without specification of site 4,722 0.00
44: Neoplasms of unspecified nature or uncertain behavior … 33,148 0.03
45: Maintenance chemotherapy; radiotherapy 5,281 0.00
46: Benign neoplasm of uterus 34,062 … 0.03
47: Other and unspecified benign neoplasm 54,805 0.04
48: Thyroid disorders 38,709 0.03
49:
-
effectivehealthcare.ahrq.gov/products/renal-cancer/research-protocol
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/breast-cancer-screening
May 06, 2021 - and across followup, including interval cancers
Cancer subtypes will be defined by receptor status … different stage and tumor size cutpoints) *
KQ 3:
False-positive and false-negative findings at … abstracts of non–English-language papers)
* Where possible we will report outcomes for cancers … include certain types of nonrandomized studies for the assessment of effectiveness, and include interval cancers … The USPSTF also clarified the proposed approach for including interval cancers and for defining advanced
-
hcup-us.ahrq.gov/db/tools/HCUP_Formats.TXT
December 28, 2023 - diagnosis"
1 - 10 = " 1: Infectious and Parasitic DX"
11 - 47 = " 2: Neoplasms … ; other and unspecified primary"
42 = " 42: Secondary malignancies" … 43 = " 43: Malignant neoplasm without specification of site"
44 = " 44: Neoplasms … 45 = " 45: Maintenance chemotherapy; radiotherapy"
46 = " 46: Benign … neoplasm of uterus"
47 = " 47: Other and unspecified benign neoplasm"
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/c-7ARQE9RuXKjjpeLABkaH
March 01, 2007 - More than 80% of colorectal cancers arise from adeno-
matous polyps. … and has the second highest mortality
rate among cancers, incidence is decreasing. … Annual report to the nation on the status of cancer (1973 through 1998), featur-
ing cancers with recent … Low-dose
aspirin and incidence of colorectal tumors in a randomized trial. … of nonsteroidal antiinflammatory drugs and other chemopreventors and risk of
subsequent colorectal neoplasia
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
September 01, 2010 - and the most aggressive breast cancers. … Population-
based estimates of the relation between
breast cancer risk, tumor subtype, and
family … Reactivation of Tumor
Suppressor Genes in Breast Cancer by
Dietary Supplements As. 2009.
178. 5F32AT004876 … Uterine malignancy following tamoxifen use
in breast cancer patients in Iran: case series
and literature … /ep, et 10531
8 4 and 7 1164
9 exp breast neoplasms/pc, eh 7858
10 exp breast neoplasms/ge 18582
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Pboxx4DR35wz5GPozm-XNF
June 15, 2023 - review as stage IIB or higher, which encompasses tumors with
local lymph node involvement or distant … No statistically signifi-
cant differences were found in the cancer characteristics (tumor size,
nodal … Proportion of Screen-Detected Invasive Cancers Diagnosed (Advanced Stage [II or Higher], Tumor Size > … 20 mm, Tumor Grade 3,
Node-Positive Cancer) With Digital Breast Tomosynthesis vs Digital Mammography … Breast-cancer tumor size, overdiagnosis, and
mammography screening effectiveness.